CrownCast podcast

Syngeneic vs. Humanized Models: How to Choose the Right Model for Immuno-Oncology Research

9/23/2026
0:00
9:46
Rewind 15 seconds
Fast Forward 15 seconds
Choosing the right preclinical immuno-oncology model makes or breaks your development decisions, but navigating the options is rarely simple. In this CrownCast episode, host Michelle Dawn Mooney sits down with Chris Dillon, Executive Director of In Vivo at Crown Bioscience's San Diego site, to explore how syngeneic tumor models support preclinical immunotherapy research and how model selection, engineering, and translational relevance come together to build studies that deliver actionable results.

More episodes from "CrownCast"